Status:

UNKNOWN

SoundBite Hearing System 24 Month Multi Site Patient Use Study

Lead Sponsor:

Sonitus Medical Inc

Conditions:

Single Sided Deafness

Conductive Hearing Loss

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this multi-site observational study is to further assess the long-term patient use of the Sonitus SoundBite Hearing System. Information can be gained by assessing benefit for the subj...

Eligibility Criteria

Inclusion

  • Subjects who previously were enrolled in SoundBite Hearing System Long Term Multi Site Patient Use Study (Protocol CLN006) and completed the 12 month study visit.
  • Additionally, subjects must meet one of the two criteria for hearing loss:
  • Moderately severe, severe, or profound sensorineural hearing loss in one ear and normal hearing in the other ear (i.e. single sided deafness or "SSD"). Normal hearing is defined as a pure tone average (PTA) air-conduction (AC) hearing threshold (measured at 0.5, 1, 2, and 3 kHz) of better than or equal to 25 dB HL.
  • OR
  • Conductive hearing loss where the pure tone average bone-conduction hearing threshold (measured at 0.5, 1, 2, and 3 kHz) is better than or equal to 25 dB HL.

Exclusion

  • Subjects that do not meet one of the two the audiometric criteria as measured on the audiogram for the 12 month study appointment for Protocol CLN006:
  • A moderately severe, severe, or profound sensorineural hearing loss in one ear and normal hearing in the other ear (i.e. single sided deafness or -SSD‖). Normal hearing is defined as a pure tone average (PTA) air-conduction (AC) hearing threshold (measured at 0.5, 1, 2, and 3 kHz) of better than or equal to 25 dB HL.
  • Patients with conductive hearing loss where the pure tone average bone-conduction hearing threshold (measured at 0.5, 1, 2, and 3 kHz) is better than or equal to 25 dB HL
  • The SoundBite Hearing System and all portions of it are contraindicated for use in an MRI Environment and should be removed prior to MRI exposure
  • The SoundBite Hearing System is not to be used in patients with known hypersensitivity to any of the components including allergies to polymers.
  • The SoundBite Hearing system is contraindicated for vulnerable populations that are unable to use their hands such as paraplegics or others that are unable to comply with the warnings in the product's labeling.

Key Trial Info

Start Date :

March 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2014

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT01807559

Start Date

March 1 2013

End Date

August 1 2014

Last Update

May 3 2013

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Arizona Ear Center

Phoenix, Arizona, United States, 85004

2

California Hearing and Balance

La Jolla, California, United States, 92037

3

Shohet Ear Associates

Newport Beach, California, United States, 92663

4

The George Washington University-Department of Otolaryngology

Washington D.C., District of Columbia, United States, 20006